What is PEN stock price today?

Visit our real-time dashboard for the current PEN stock price and live market data.

Is PEN stock going up or down today?

PEN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PEN stock now?

The decision to buy PEN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PEN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PEN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PEN stock overvalued or undervalued?

PEN currently trades at a P/E ratio of 237.44, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if PEN is fairly priced.

What is PEN's P/E ratio?

PEN has a price-to-earnings (P/E) ratio of 237.44, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is PEN's market cap?

PEN (Penumbra Inc) has a market capitalization of $9.93 billion, making it a small-cap stock.

What is PEN's price to book ratio?

Price-to-book ratio for PEN is available on our dashboard along with other valuation metrics.

Does PEN pay dividends?

PEN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PEN's dividend yield?

PEN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PEN stock a good long-term investment?

PEN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PEN's revenue growth rate?

Revenue growth data for PEN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PEN are available on our dashboard with complete income statement analysis.

What are the risks of investing in PEN?

Key risks for PEN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PEN compare to its competitors?

Compare PEN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PEN's performance and positioning.

What is PEN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for PEN with bull, base, and bear case scenarios.

What do analysts say about PEN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PEN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PEN's next earnings report?

PEN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PEN - Penumbra Inc

NYSE * Healthcare * Medical Devices

$0.00

+$0.00 (+0.00%)

About Penumbra Inc

Penumbra Inc (PEN) common stock

Price Chart

Loading chart...

PEN Key Statistics

Market Cap

$9.93B

P/E Ratio

237.44

How PEN Compares to Peers

PEN trades at a premium valuation vs peers (highest P/E)

PEN is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PEN(This stock)	$9.93B	237.4	0%	0.0%	-
ABTAbbott Laboratories	$154.15B	24.8	0%	0.0%	vs ABT
MDTMedtronic PLC	$100.08B	20.9	0%	0.0%	vs MDT
SYKStryker Corporation	$115.45B	34.9	0%	0.0%	vs SYK
BSXBoston Scientific	$71.81B	20.2	0%	0.0%	vs BSX
ISRGIntuitive Surgical	$195.15B	80.0	0%	0.0%	vs ISRG

Data Updated: July 18, 2026 at 11:08 PM EDT

Ready to invest in PEN?

Commission-free trading available. Affiliate links.

PEN Lician Score

10% confidence

6.0/10

Good

PEN has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

9.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates PENacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

PEN Financial Snowflake

5-axis analysis across key investment dimensions

5.8/10

Neutral

5.0

Value

Valuation vs. sector peers

9.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for PEN

Dashboard

Enter a ticker to analyze